iAnthus Capital (ITHUF) Stock Price, News & Analysis

Company Overview

iAnthus Capital (OTCMKTS: ITHUF) is a multi-state operator in the U.S. medical cannabis industry. The company acquires, develops and manages licensed cultivation, processing and retail facilities in regulated state markets. Its core business activities include the cultivation of cannabis flower, the manufacturing of extracts and infused products such as oils, edibles and topicals, and the operation of dispensaries under various regional brands.

Through a network of subsidiaries and strategic acquisitions, iAnthus holds medical cannabis licenses in multiple states, including Florida, New York, Massachusetts and Maryland. The company’s cultivation sites follow Good Manufacturing Practices (GMP) standards, and its vertically integrated model allows for tight control over quality, traceability and compliance from seed to sale. Retail operations are branded to reflect local market preferences, featuring educational programs for patients and caregivers.

Founded in 2014, iAnthus Capital originally listed on the Canadian Securities Exchange before expanding its footprint across the United States. Growth has been driven by targeted acquisitions, including the 2020 business combination with MPX Bioceutical, which broadened the company’s presence in southeastern markets. iAnthus has positioned itself as a partner of choice for state regulators, emphasizing a patient-centric approach and adherence to evolving legal frameworks.

Headquartered in New York, iAnthus is led by CEO Hadley Ford, whose background spans regulated-market operator development and public company management. The senior leadership team focuses on operational excellence, state licensing strategy and the development of differentiated product portfolios. With a blend of cultivation expertise and retail experience, the company seeks to capture emerging opportunities as new markets open to medical and adult-use cannabis.

Key Stats

• Today's Range: $0.0045 to $0.0047
• 50-Day Range: N/A
• 52-Week Range: $0.0031 to $0.0133
• Volume: 151,010 shs
• Average Volume: 307,955 shs
• Market Capitalization: N/A
• P/E Ratio: 0.03
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: Agriculture
• Current Symbol: OTCMKTS:ITHUF
• CIK: 1643154
• Web: www.ianthuscapital.com
• Phone: 646-518-9411
• Fax: N/A
• Employees: 1,000
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 0.03
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A